Armetheon, FDA Reach Agreement Prior to New Drug Filing for Tecarfarin
News
Armetheon and the U.S. Food and Drug Administration (FDA) have reached an agreement for a Phase 3 trial of drug candidate Tecarfarin, prior to a new drug application (NDA) filing projected ... Read more